Institutional Ownership Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX). We have compiled data on the 657 institutions that hold shares in the stock, with a total of 102 Million shares, which have been reported (via 13F filing form) to have a value of $14.6 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Clearbridge Investments, LLC
New York, NY |
Aug 12, 2025 Q2 2025 |
342,302
shares
|
$49.3 Million
0.04% of portfolio
|
Q1 2025
Added 7.2%
|
|
|
Axa S.A.
Paris, I0 |
Aug 14, 2025 Q2 2025 |
341,734
shares
|
$49.3 Million
0.13% of portfolio
|
Q2 2025
Added 2.41%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
341,578
shares
|
$49.2 Million
0.08% of portfolio
|
Q2 2025
New holding
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
322,064
shares
|
$46.4 Million
0.02% of portfolio
|
Q2 2025
Reduced 30.92%
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
309,190
shares
|
$44.6 Million
0.03% of portfolio
|
Q2 2025
Reduced 1.68%
|
|
|
Sarissa Capital Management LP
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
303,151
shares
|
$43.7 Million
28.38% of portfolio
|
Q2 2025
Reduced 1.93%
|
|
|
Candriam S.C.A.
|
Aug 08, 2025 Q2 2025 |
298,551
shares
|
$43 Million
0.22% of portfolio
|
Q2 2025
Reduced 9.76%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
289,245
shares
|
$41.7 Million
0.01% of portfolio
|
Q2 2025
Reduced 49.02%
|
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
285,500
shares
|
$41.2 Million
0.02% of portfolio
|
Q1 2025
Added 0.07%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
284,338
shares
|
$41 Million
0.01% of portfolio
|
Q2 2025
Added 11.33%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
271,390
shares
|
$39.1 Million
0.01% of portfolio
|
Q2 2025
Added 35.55%
|
|
|
Macquarie Group LTD
Australia, C3 |
Aug 14, 2025 Q2 2025 |
270,502
shares
|
$39 Million
0.04% of portfolio
|
Q2 2025
Added 16.92%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
267,980
shares
|
$38.6 Million
0.01% of portfolio
|
Q4 2024
Reduced 22.45%
|
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Aug 14, 2025 Q2 2025 |
257,538
shares
|
$37.1 Million
0.52% of portfolio
|
Q2 2025
Reduced 23.62%
|
|
|
Perceptive Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
255,050
shares
|
$36.8 Million
1.41% of portfolio
|
Q2 2025
Added 154.92%
|
|
|
Renaissance Group LLC
Covington, KY |
Aug 11, 2025 Q2 2025 |
251,732
shares
|
$36.3 Million
1.27% of portfolio
|
Q2 2025
Added 18.69%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Aug 07, 2025 Q2 2025 |
248,633
shares
|
$35.8 Million
0.12% of portfolio
|
Q2 2025
Added 345.06%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Aug 08, 2025 Q2 2025 |
243,730
shares
|
$35.1 Million
0.02% of portfolio
|
Q2 2025
Reduced 1.89%
|
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Jul 31, 2025 Q2 2025 |
235,488
shares
|
$34 Million
0.02% of portfolio
|
Q2 2025
Added 1.74%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
228,862
shares
|
$33 Million
0.01% of portfolio
|
Q2 2025
Reduced 20.12%
|
|
|
Eagle Health Investments LP
Greenwich, CT |
May 12, 2025 Q1 2025 |
225,100
shares
|
$32.5 Million
6.46% of portfolio
|
Q1 2025
Added 45.23%
|
|
|
Sei Investments CO
Oaks, PA |
Aug 14, 2025 Q2 2025 |
220,759
shares
|
$31.8 Million
0.03% of portfolio
|
Q2 2025
Added 56.1%
|
|
|
Amundi
Paris, I0 |
Aug 13, 2025 Q2 2025 |
219,195
shares
|
$31.6 Million
0.01% of portfolio
|
Q2 2025
Reduced 5.19%
|
|
|
Zurich Insurance Group LTD
Zurich, V8 |
Aug 14, 2025 Q2 2025 |
211,911
shares
|
$30.6 Million
0.21% of portfolio
|
Q2 2025
New holding
|
|
|
Capital Fund Management S.A.
Paris, I0 |
Aug 13, 2025 Q2 2025 |
203,628
shares
|
$29.4 Million
0.07% of portfolio
|
Q2 2025
Added 15.93%
|